# Study of AZD0754 in Participants With Metastatic Prostate Cancer

> **NCT06267729** · PHASE1,PHASE2 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 60 (estimated)

## Conditions studied

- Metastatic Prostate Cancer

## Interventions

- **BIOLOGICAL:** AZD0754
- **BIOLOGICAL:** AZD2287

## Key facts

- **NCT ID:** NCT06267729
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-12
- **Primary completion:** 2026-11-24
- **Final completion:** 2026-11-24
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06267729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06267729, "Study of AZD0754 in Participants With Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06267729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*